Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2026-01-28 @ 10:05 PM
Study NCT ID:
NCT05275205
Status:
COMPLETED
Last Update Posted:
2024-08-07
First Post:
2022-02-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION)
Sponsor:
Organization: